ArticleIJID regions2025
Spatial heterogeneities in women's adherence to sulfadoxine pyrimethamine prophylaxis in Tanzania: Findings from the 2022 TDHS-MIS.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Most pregnant women in Tanzania do not adhere to the recommended use of SP/Fansidar for malaria prevention, posing a significant challenge to malaria control efforts. The study examines zonal heterogeneities in the uptake of SP/Fansidar doses in Tanzania. Methods: This cross-sectional study analyzed 2022 TDHS-MIS data to examine sociodemographic and geographic determinants of sufficient SP/Fansidar uptake among pregnant women in Tanzania. Results: Among 4157 women aged 15-49, those with secondary or higher education were 1.37 times more likely to take three or more SP/Fansidar doses, while women aged 35-39 were 34% less likely than those aged 15-19. SP/Fansidar doses uptake was higher in the Northern (adjusted odds ratio [aOR] = 1.78), Lake (aOR = 1.57), Southern (aOR = 1.44), and Eastern (aOR = 1.38) zones but 73% lower in Zanzibar (aOR = 0.27). Conclusions: Uptake of ≥3 SP/Fansidar doses among women in Tanzania remains generally low, with significant disparities across geographic zones and sociodemographic groups. The Northern, Southern, Lake, and Eastern zones show higher coverage, while Zanzibar lags substantially behind. Factors such as place of residence, education, maternal age, wealth status, and parity are key determinants, underscoring the need for carefully designed, geographically targeted interventions to improve SP/Fansidar adherence in the most affected zones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.